X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ORCHID PHARMA LTD ALKEM LABORATORIES/
ORCHID PHARMA LTD
 
P/E (TTM) x - -0.8 - View Chart
P/BV x 6.2 0.5 1,134.0% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 ALKEM LABORATORIES   ORCHID PHARMA LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
ORCHID PHARMA LTD
Sep-13
ALKEM LABORATORIES/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs1,589194 819.1%   
Low Rs1,23235 3,520.0%   
Sales per share (Unadj.) Rs417.5276.5 151.0%  
Earnings per share (Unadj.) Rs56.3-79.2 -71.1%  
Cash flow per share (Unadj.) Rs64.7-43.5 -148.9%  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.953.9 543.1%  
Shares outstanding (eoy) m119.5770.45 169.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.40.4 815.8%   
Avg P/E ratio x25.1-1.4 -1,733.3%  
P/CF ratio (eoy) x21.8-2.6 -827.2%  
Price / Book Value ratio x4.82.1 226.8%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,6538,067 2,090.8%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m9,1712,527 362.9%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m49,91519,477 256.3%  
Other income Rs m1,645407 404.0%   
Total revenues Rs m51,56119,884 259.3%   
Gross profit Rs m8,4821,103 769.3%  
Depreciation Rs m1,0062,519 39.9%   
Interest Rs m6715,227 12.8%   
Profit before tax Rs m8,451-6,236 -135.5%   
Minority Interest Rs m-11420 -577.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m1,606-125 -1,282.7%   
Profit after tax Rs m6,731-5,580 -120.6%  
Gross profit margin %17.05.7 300.2%  
Effective tax rate %19.02.0 946.6%   
Net profit margin %13.5-28.7 -47.1%  
BALANCE SHEET DATA
Current assets Rs m27,06211,014 245.7%   
Current liabilities Rs m15,32432,060 47.8%   
Net working cap to sales %23.5-108.1 -21.8%  
Current ratio x1.80.3 514.1%  
Inventory Days Days6795 70.1%  
Debtors Days Days4134 123.0%  
Net fixed assets Rs m12,61029,440 42.8%   
Share capital Rs m239705 33.9%   
"Free" reserves Rs m34,4902,043 1,688.5%   
Net worth Rs m35,0273,800 921.8%   
Long term debt Rs m1,2129,018 13.4%   
Total assets Rs m54,38746,510 116.9%  
Interest coverage x13.6-0.2 -7,043.4%   
Debt to equity ratio x02.4 1.5%  
Sales to assets ratio x0.90.4 219.2%   
Return on assets %13.6-0.8 -1,790.6%  
Return on equity %19.2-146.9 -13.1%  
Return on capital %24.9-3.7 -665.6%  
Exports to sales %12.937.9 34.2%   
Imports to sales %3.122.6 13.6%   
Exports (fob) Rs m6,4617,378 87.6%   
Imports (cif) Rs m1,5404,406 35.0%   
Fx inflow Rs m6,5637,513 87.4%   
Fx outflow Rs m3,0125,649 53.3%   
Net fx Rs m3,5521,865 190.5%   
CASH FLOW
From Operations Rs m7,2591,682 431.6%  
From Investments Rs m1,864-9,860 -18.9%  
From Financial Activity Rs m-9,2736,644 -139.6%  
Net Cashflow Rs m-150-1,535 9.8%  

Share Holding

Indian Promoters % 66.9 32.3 207.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 4.6 719.6%  
FIIs % 0.0 3.3 -  
ADR/GDR % 0.0 4.6 -  
Free float % 0.0 55.3 -  
Shareholders   68,381 84,811 80.6%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   MERCK LTD  CIPLA  TORRENT PHARMA  ALEMBIC LTD  WYETH LTD  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 21, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - CADILA HEALTHCARE COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS